Ecuador vs Venezuela, Bolivarian Republic of: TB patients with known HIV status
Ecuador
66.0%
in 2024
Venezuela, Bolivarian Republic of
69.0%
in 2024
Ecuador rank
154th
Venezuela, Bolivarian Republic of rank
151st
TB patients with known HIV status over time
- Ecuador
- Venezuela, Bolivarian Republic of
How they compare
Venezuela, Bolivarian Republic of currently reports 69.0% against 66.0% in Ecuador, a difference of 3.0%.
The two have swapped places 2 times across 19 shared years of data; in 2005 it was Venezuela, Bolivarian Republic of ahead.
Ecuador ranks 154th and Venezuela, Bolivarian Republic of ranks 151st of 181 countries.
Across the 3 decades both report, Ecuador averaged higher in 2 and Venezuela, Bolivarian Republic of in 1.
Head to head by decade
| Decade | Ecuador | Venezuela, Bolivarian Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.3% | 57.5% | 33.2% | Venezuela, Bolivarian Republic of |
| 2010s | 86.9% | 64.0% | 22.9% | Ecuador |
| 2020s | 71.6% | 52.4% | 19.2% | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tb patients with known hiv status, Ecuador or Venezuela, Bolivarian Republic of?
- Venezuela, Bolivarian Republic of, at 69.0% against 66.0% in Ecuador as of 2024.
- What is the difference in tb patients with known hiv status between Ecuador and Venezuela, Bolivarian Republic of?
- 3.0%, with Venezuela, Bolivarian Republic of ahead.
- How many years of comparable data are there for Ecuador and Venezuela, Bolivarian Republic of?
- 19 years are reported by both, from 2005 to 2024.
- How do Ecuador and Venezuela, Bolivarian Republic of rank globally for tb patients with known hiv status?
- Ecuador ranks 154th and Venezuela, Bolivarian Republic of ranks 151st of 181 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as TB patients with known HIV status (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.